U-M to conduct clinical trial to test AstraZeneca COVID-19 vaccine

Author | Kelly Malcom

Michigan Medicine is partnering with the pharmaceutical company AstraZeneca for a Phase 3 clinical trial to test a vaccine against COVID-19. The AZD1222 COVID-19 VACCINE Study will research an investigational vaccine for the prevention of COVID-19, the disease caused by the new coronavirus (SARS-CoV-2).

The study will look at how well the investigational vaccine works and how safe it is. U-M will begin recruiting hundreds of participants for the trial immediately, until the trial is full. U-M is one of several U.S. sites supporting the AstraZeneca trial, with the aim of including 30,000 individuals over a period of two years.

“The importance of a safe and effective vaccine against COVID-19 cannot be overstated. The AstraZeneca Phase III trial will bring answers as to the effectiveness of this vaccine. At the end of the day, this kind of rigorous clinical trial with the commitment of Michigan Medicine and other study sites to safety will be a key step in realizing a vaccine that will save lives when one is developed,” says Marschall Runge, M.D., Ph.D., Dean, U-M Medical School, Executive Vice President, Medical Affairs and CEO, Michigan Medicine.

The AstraZeneca trial is one of several vaccine trials being funded through a public/private partnership under the U.S. Department of Health and Human Services called Operation Warp Speed. It is designed to accelerate the development of a life-saving vaccine to prevent COVID-19, while maintaining standards for safety and efficacy.

“We are proud to advance the University of Michigan's outstanding legacy of excellence in vaccine trials with this important clinical trial partnership. We hope one day soon to be able to announce a successful vaccine against COVID-19 and save lives,” says Mark Schlissel, M.D., Ph.D., president of the University of Michigan.

Phase I/II trials of the vaccine in more than 1000 people were completed earlier this year and demonstrated increased antibody responses against SARS-CoV-2 and no serious adverse effects.

For more information about the study, visit https://www.uofmhealth.org/covid19-vaccine or email [email protected].
Media Contact Public Relations

Department of Communication at Michigan Medicine

[email protected]

734-764-2220

Featured News & Stories young adult man standin infront of welcome to michigan yellow sign and a photo next to that one of him sitting with a man standing next to him in glasses and UM badge and button down light blue shirt
Health Lab
Timely CPR saves runner who collapsed during first week of college
Bystander CPR saves a college freshman who collapsed from sudden cardiac arrest while running during his first week of school.
 Minding Memory with a microphone and a shadow of a microphone on a blue background
Minding Memory
Can a Serious Infection Increase the Risk of Developing Dementia?
In this episode, Lauren and Matt talk with Leah Richmond-Rakerd, PhD who is an Assistant Professor in the Department of Psychology at the University of Michigan. Her research focuses on emotional and behavioral dysregulation across the life course. Here, Dr. Richmond-Rakerd will discuss her recent study on “The Associations of Hospital-Treated Infections with Subsequent Dementia: Nationwide 30-year Analysis” that was published in Nature Aging.
 Blue umbrella with cross health insurance
Health Lab
Don’t choose health insurance for 2025 until you read this
Health insurance choices for 2025 have changed for Medicare, healthcare.gov and employer plans, and costs have too. An update on what’s most important to consider.
 surgery-general-aerial
News Release
Service Employees International Union workers reach tentative agreement with University of Michigan Health
SEIU Healthcare Michigan, U-M Health announce tentative collective bargaining agreement
 close up of yellow cells and blue greenish teal background
Health Lab
An ultrasound-activated hydrogel for steady, sustained drug delivery
Researchers have developed a new composite hydrogel capable of achieving sustained, zero-order drug release using ultrasound as a trigger.
 Health Lab Podcast in brackets with a background with a dark blue translucent layers over cells
Health Lab Podcast
New study finds steep increase in ED visits for hypertensive disorders of pregnancy, and shows persistent maternal health disparities
Findings suggest significant increase in emergency department utilization for hypertensive disorders of pregnancy over 14 year span.